CLINICAL TRIALS PROFILE FOR TACHOSIL
✉ Email this page to a colleague
All Clinical Trials for TACHOSIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00285623 ↗ | Observational Cohort Study of TachoSil (TC-018-IN) | Completed | Nycomed | 2005-12-01 | The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bleeding. In addition, pharmacoeconomic data will be collected. | |
NCT00293514 ↗ | TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM) | Completed | Nycomed | Phase 3 | 2006-02-01 | The purpose of this study is to compare the sealing efficacy and safety of TachoSil® (hereafter referred to as TachoSil) versus standard surgical treatment as the secondary management of intra-operative pulmonary air leakage after a lobectomy in subjects with lung malignancies with or without metastases. |
NCT00365248 ↗ | TachoSil Paediatric Liver Trial (TC-019-IN) | Completed | Nycomed | Phase 3 | 2005-10-01 | The overall objective is to assess the haemostatic efficacy and safety of TachoSil for control of local bleeding in paediatric patients undergoing surgical resection of the liver with our without segmental liver transplantation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TACHOSIL
Condition Name
Clinical Trial Locations for TACHOSIL
Trials by Country
Clinical Trial Progress for TACHOSIL
Clinical Trial Phase
Clinical Trial Sponsors for TACHOSIL
Sponsor Name